Skip to main content
. Author manuscript; available in PMC: 2013 Sep 16.
Published in final edited form as: AIDS Rev. 2013 Jan-Mar;15(1):15–24.

Table 3.

†††: Plasma Half-Lives of WHO-recommended First and Second-Line Antiretroviral Therapy

Plasma Half-Lives (hours)
NRTIs
 Lamivudine 5–9
 Zidovudine 0.5–3
 Emtricitabine 8–10
 Tenofovir 12–15
NNRTIs
 Efavirenz 40–100
 Nevirapine 25–60
PIs
 Atazanavir 4–24
 Lopinavir 5–6
 Ritonavir 3–8
†††

Abbreviations: NRTIs- nucleoside reverse transcriptase inhibitors, NNRTIs- non-nucleoside reverse transcriptase inhibitors, PIs - Protease Inhibitors.